Skip to content

Consequences of Hypoglycemia on Intensive Care Unit (ICU) Patients

Does Hypoglycemia Under Intensive Insulin Therapy During Critical Illness Lead to Neurocognitive Dysfunction

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00662922
Enrollment
74
Registered
2008-04-21
Start date
2008-04-30
Completion date
2008-09-30
Last updated
2010-01-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Critical Illness

Keywords

critical illness, hypoglycemia, neurocognitive dysfunction, intensive insulin therapy

Brief summary

Hypoglycemia occurs frequently during intensive blood glucose control in critically ill patients. The incidence of hypoglycaemia is associated with impaired outcome. However, it is hitherto unknown if hypoglycaemia itself predisposes patients to neurological impairment, e.g. cognitive dysfunction, or if it is the underlying medical condition that makes the patient prone to a high risk of hypoglycaemia and, concomitantly, neurocognitive impairment. Therefore we investigate neurocognitive function in patients who had hypoglycemias during their intensive care stay and compare the results to patients without hypoglycaemia whose medical conditions are matched to the hypoglycaemia patients.

Interventions

None listed

Sponsors

University Hospital Muenster
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* all patients

Exclusion criteria

* clinical diagnosis of diabetes mellitus * brain injury of any kind prior to or upon ICU-admission * pre-existing mental or psychiatric disorder * terminal kidney or liver failure prior admission * drug abuse, * CPR \> 5 min * HIV * Lues

Design outcomes

Primary

MeasureTime frame
neurocognitive function1 year after ICU discharge

Secondary

MeasureTime frame
neurocognitive function2,3, and 4 years after ICU discharge

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026